Why are BI oncology reps paid more than the rest of the company?

Discussion in 'Boehringer Ingelheim' started by anonymous, Feb 9, 2016 at 11:13 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Heard Adam was interviewing at AZ. Did he land that job and take his talents there?
     

  2. anonymous

    anonymous Guest

    LOL —-Talents? Ha ha
     
  3. anonymous

    anonymous Guest

    Kirsch?
     
  4. anonymous

    anonymous Guest

    Yes! AK! The question remains, why would this dolt be interviewing like crazy with other companies, when he has the most cush job with no responsibility? I think I know who may have it out for him... just speculating though.
     
  5. anonymous

    anonymous Guest

    My goodness. You people are really mean. It takes a lot of courage to make fun of people behind your keyboard. Don’t you think he has come a long way? I remember when he came to one of our breakout sessions and tried to explain what he does. He was really cute and really nervous. It was funny how many times he said “ya know” in a sentence. It was like watching an post-game NBA interview. I tried to make eye-contact with him, but he kept looking down and shuffled his feet. He knew what I was up to. Someone said his better half was on the heavy side too which makes me think I have a chance. Not sure if he plays around at meetings like some of his superiors, but I sure want to find out.
     
  6. anonymous

    anonymous Guest

    Ward used to do an impression of him that was “spot on”

     
  7. anonymous

    anonymous Guest

    Truth, BI Onc is the laughing stock of the industry. If one of the pipeline drugs makes it to market this bunch of oncology rejects will surely fail the company and the patients that deserve better....again
     
  8. anonymous

    anonymous Guest

    BI Oncology is the sweet spot of The company
    Yes several people with onc experience have been at other companies
    To refer to these elite professionals as losers is only a sign of envy. They overcome access obstacles and achieve their sales goals for the company.
    It takes tenacity to work in this field which most of the primary care reps do not understand
     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    50 million of gilotrif sold to date in 2019 and still behind goal. Sweet spot my arse. The onc sales team isn’t even carrying its own water.
     
  11. anonymous

    anonymous Guest

    How can you argue that oncology is not the sweet spot? For example, look at the fella the previous posts were referring to. Perfect example of a person overpaid and under qualified. Produces nothing, and continues to thrive in the organization. We are untouchable in this organization.
     
  12. anonymous

    anonymous Guest

    Why are you so obsessed with this person? He is a NOBODY!!!
     
  13. anonymous

    anonymous Guest

    I agree. Calling him a nobody is a little harsh. The word insignificant, may be more appropriate. Let’s try and be a little nicer to our peers.
     
  14. anonymous

    anonymous Guest

    This thread is stupid. Go away!
     
  15. anonymous

    anonymous Guest

    He’s a dolt
     
  16. anonymous

    anonymous Guest

    the man crush a bloomin onion like no one I have ever seen.
     
  17. anonymous

    anonymous Guest

    I left this p.o.s. “Oncology” company over a year ago to join a small oncology biotech. How you are all still a division amazes me. The leadership, and product are a joke. AK, the person I think you are referring to in this thread, is probably the most useless person I have ever encountered in 15 years of oncology. Is he in fact, still employed? Y’all need to get the hell out.
     
  18. anonymous

    anonymous Guest

    Please, please, please stop talking about this guy. He truly is a nobody and this nonsense is hijacking an otherwise, good thread.
     
  19. anonymous

    anonymous Guest

    goodbye Doug. You’ll be missed. Thanks for abandoning this sinking ship.
     
  20. anonymous

    anonymous Guest

    At least it will give Kirsch a hope of getting out of here. Without him, he’s sinking with us.